Cerebral hemocirculatory disturbances are among the poorly studied pathogenetic factors of epilepsy. At the same time the facts of the increased level of paroxysmal propensity of the brain in the presence of chronic dyscirculatory hypoxia of neurons [7, 13], the emergence of an epileptic syndrome in acute cerebrovascular diseases [2, 10], the substantial similarity of the histologic changes of the brain in epilepsy with a pathomorphological substrate of chronic cerebral ischemia [11], the close association between epilepsy and migraine [6], and finally, the outward appearance of the epileptic paroxysm as a vascular crisis [5], are well known. All these facts permit the hypothesis that dyshemic disorders may play a role in the formation, development, and compensation of the paroxysmal activity of the brain. It is well known at the present time that an increase in cerebral blood flow takes place at the moment of a full-scale epileptic paroxysm [4, 8]. However, the changes in blood flow in response to a subthreshold, subclinical increase in paroxysmal activity have not been studied. This is of special significance for the study of the influence of the level of paroxysmal activity of the brain in the interictal period, when its fluctuations are accompanied by varying intensities of the metabolic processes, and, consequently, must also have a varying level of vascular supply. In the opinion of some authors [14, 15], the hemodynamic changes in the interictal period of epilepsy are manifested by a decrease in blood flow which is most marked in the epileptic focus. Other investigators [1] direct attention to the possibility of compensatory intensification of hemocirculation in the epileptic focus. An increase in local cerebral blood flow under the influence of the cerebrospinal fluid of epilepsy patients has also been demonstrated in experiments on animals [3]. It may also be noted that the level of the blood supply of the epileptic brain has not until now been established, the association of the hemodynamic disturbances with the clinical features of the disease has not been precisely defined, and the effect of anti-epileptic and vasoactive preparations on the state of the cerebrovascular bed in epilepsy patients has not been studied. We carried out an investigation of cerebral blood flow (CBF) in 75 epilepsy patients, aged from 15 to 53 years, without signs of accompanying cardiovascular diseases. Of those examined, 62 patients were younger than 40 years, which made it possible to reduce the influence of age-related factors on hemodynamics. The duration of the illness was less than five years in 36 patients, 5-10 years in 14 cases, and more than 10 years in 25. Attacks were rare in 25 individuals; they were of average frequency in 21; and they were frequent in 34 patients. The verification of the clinical diagnosis of epilepsy was accomplished though analysis of the EEG. According to H. Gastaut's classification [9], generalized secondary epilepsy (lst group) was diagnosed in 23 patients, focal temporal epilepsy (2nd group) was diagnosed in 30 patients, and focal precentral epilepsy (3rd group) was diagnosed in 22 patients. The principal method of studying the cerebral hemocirculation was radionuclide cerebral circulography (RCC). It was carfled out on an NC-110 unit (Hungary).131I-Albumin injected into the cubital vein was employed as the indicator. The cerebral blood flow time (CBb-T), the accumulation half-time Talt2, and the elimination half-time Tblr z were determined separately for each hemisphere. The radionuclide investigation of the linear cerebral blood flow (LCBF) was supplemented by the recording of the REG. We studied the baseline level of the hemocirculation prior to the prescription of treatment (47 individuals) or on the ffth day after it was discontinued (28 observations), as well as the dynamics of the CBF during a gradual increase in epileptic activity by means of the intravenous administration of corazole (48 observations) or by means of three minutes of hyperventilation (16 observations) under EEG monitoring. The investigation was repeated on the 10th to 15th day of treatment with pheobarbital, as well as its combination with papaverine or caffeine.
Read full abstract